Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
Clinical trial NCT01059344 · COMPLETED
Trial details
- NCT number
- NCT01059344
- Sponsor
- Tillotts Pharma AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-07-01
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.